Pure Global

Drug of Abuse Rapid Test- Morphine-300mg/ml - India CDSCO Medical Device Registration

Drug of Abuse Rapid Test- Morphine-300mg/ml is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2018/000029_d62b53b15c3bb5f902d295de5f972433_da61810827f35ec92d5c7a3a54d4d3d1. This device is marketed under the brand name Merilisa. The license holder is Meril Diagnostics Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, Ahmedabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Drug of Abuse Rapid Test- Morphine-300mg/ml
UID: MFG/MD/2018/000029_d62b53b15c3bb5f902d295de5f972433_da61810827f35ec92d5c7a3a54d4d3d1

Brand Name

Merilisa

Device Class

Class C

Approving Authority

Central Drug Standards Control Organization, Ahmedabad

Product Information

Drug of Abuse(Merilisa)Rapid Test Morphine-300mg/ml is a qualitative immunoassay intended to be used to detect the presence of Morphine drugs and/or their metabolites at or above the specified cut of level in human urine in a single assay

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing